Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure: A Randomized Controlled Trial "LEVMag Trial"

NCT07220902 is registered in ClinicalTrials.gov with Nebraska Methodist Health System as lead sponsor.

NCT NCT07220902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure: A Randomized Controlled Trial "LEVMag Trial"
Lead sponsor
Nebraska Methodist Health System
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
July 31, 2034
Enrollment
1,240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eclampsia preeclampsia, severe preeclampsia